Dual Impact Channel This Pharmaceutical Company Is Growing — Here’s How to Invest By Karrie GordonMay 6, 2022
Leveraged & Inverse Channel 3 ETFs to Access a Changing Pharmaceutical Industry By Ben HernandezAugust 16, 2021
Equity ETF Channel Biotech ETFs Make Gains Tuesday, Despite the J&J Vaccine Pause By Ian YoungApril 13, 2021
Leveraged & Inverse Channel PILL Hasn’t Been a Bitter ETF to Swallow The Past Month By Ben HernandezDecember 23, 2020
Beyond Basic Beta Channel 4 ETFs to Consider with Big Pharma on the Senate’s Hot Seat By Ben HernandezApril 9, 2019
